United States · FDA National Drug Code directory

Duloxetine

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
0228-2892_8b9c71de-82c9-44a5-b2d5-8c6b3141e4ef
Product NDC
0228-2892
Form
CAPSULE, DELAYED RELEASE PELLETS
Composition / generic term
Duloxetine
Labeler
Actavis Pharma, Inc.
Marketing category
ANDA
Marketing start / end (source format)
20131217
Source listing expiry
20271231

Source-listed ingredients

  • DULOXETINE HYDROCHLORIDE — 60 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

  • 30 CAPSULE, DELAYED RELEASE PELLETS in 1 BOTTLE (0228-2892-03) · 0228-2892-03
  • 1000 CAPSULE, DELAYED RELEASE PELLETS in 1 BOTTLE (0228-2892-96) · 0228-2892-96

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →